The 2009/2010 Influenza A (H1N1) is one of several viruses responsible for respiratory-related infections. A new study from Rhode Island Hospital examined patients with viruses and found distinguishing characteristics of the H1N1 virus in how it affects respiratory illness. Their findings were presented Oct. 22 at the annual meeting of the Infectious Diseases Society of America held in Vancouver.
Phil Chan, MD, an infectious diseases fellow at Rhode Island Hospital, studied the signs, symptoms, and laboratory findings of 668 adult and pediatric patients who were treated at Rhode Island Hospital or its partner, The Miriam Hospital, between October and December 2009 with a confirmed viral infection.
Chan says, "Compared to patients with other viruses, individuals with novel Influenza A, or H1N1, were more likely to present with subjective fever, cough, sore throat, nausea/vomiting. The mean white blood count of patients with H1N1 is lower than with other viruses as well."
Leonard Mermel, DO, medical director of epidemiology and infection control at Rhode Island Hospital and professor of medicine at The Warren Alpert Medical School of Brown University, is a co-author. Mermel adds, "Perhaps more striking is that patients with the novel Influenza A virus may have higher mortality rates compared to other respiratory viruses in the patients studied. As a result of this study, and based on available data in the literature, we recommend that high-risk patients infected with novel Influenza A receive expedient antiviral therapy." Mermel is also a physician with University Medicine.
Other researchers in the study with Chan and Mermel include Kimberle Chapin, MD; Saran Andrea, Russell McCulloh, MD; John Mills, MD; Ignacio Echenique, MD; Emily Leveen, MD; Natasha Rybak, MD; Cheston Cunha, MD, Jason Machan, PhD, all of Rhode Island and Miriam hospitals and Alpert Medical School.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.